Regional patterns in the incidence of aplastic anemia in Thailand
β Scribed by Issaragrisil, Surapol; Leaverton, Paul E.; Chansung, Kanchana; Thamprasit, Tharatorn; Porapakham, Yaowarat; Vannasaeng, Sathit; Piankijagum, Anong; Kaufman, David W.; Anderson, Theresa E.; Shapiro, Samuel; Young, Neal S.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 50 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
The annual incidence of aplastic anemia has been determined in a rigorous and standardized epidemiologic study conducted in Thailand. A total of 374 cases were identified over a period of 3-6 years in three geographically defined and distinct regions of the country; Bangkok, Khonkaen in the northeast, and Songkla in the south. The incidence was 3.9 cases per million persons in Bangkok, 3.0 per million in Songkla, and 5.0 per million in Khonkaen. These rates are as high or higher than in any region of Europe or Israel as reported in the International Agranulocytosis and Aplastic Anemia Study, in which the methods and case definition were the same. Rates were stable over the course of the study. There were marked differences in incidence between northern and southern rural regions of Thailand, and among Bangkok suburbs. These differences, together with an unusual peak in the incidence among young people in Bangkok, suggest the possibility of occupational and environmental factors in the etiology of aplastic anemia. Am.
π SIMILAR VOLUMES
FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article
As indicated in the article, rates for earlier years have been presented previously, but this is the first time the data have been extended through 1994. The authors appreciate the sustained high quality registry operations of the Surveillance, Epidemiology, and End Results (SEER) program participa